Rapid progress in identifying biomarkers that are hallmarks of disease has increased
demand for high-performance detection technologies. Implementation of electrochemical …

Development of biosensing platforms plays a key role in research settings for identification
of biomarkers and in clinical applications for diagnostics. Biosensors based on nucleic acids …

Liquid biopsy is a new diagnostic concept that provides important information for monitoring
and identifying tumor genomes in body fluid samples. Detection of tumor origin …

Over the past decades, significant progress has been made in targeted cancer therapy. In
precision oncology, molecular profiling of cancer patients enables the use of targeted cancer …

Early cancer diagnosis is of prime importance as it paves the way for effective treatment and
possible patient survival. The recent advancements in the field of biosensorics have …

Liquid biopsy for the analysis of circulating cancer biomarkers (CBs) is a major
advancement toward the early detection of cancer. In comparison to tissue biopsy …

Over the last decade, significant progress has been made towards the development of
approaches that enable the capture of rare circulating tumor cells (CTCs) from the blood of …

In this work, we developed a simple electrochemical method for ultrasensitive and label-free
detection of circulating tumor cells (CTCs) based on direct plasmon-enhanced …

The detection of biomarkers using sensitive and selective analytical devices is critically
important for the early stage diagnosis and treatment of diseases. The synergy between the …

Microfluidics is an emerging field in diagnostics that allows for extremely precise fluid control
and manipulation, enabling rapid and high-throughput sample processing in integrated …